Senate Bill 316, titled "Lower Healthcare Costs," is a broad healthcare transparency and consumer-protection measure affecting hospitals, ambulatory surgical facilities, insurers, healthcare providers, and the State Health Plan. The bill expands existing price-disclosure requirements by directing hospitals and ambulatory surgical facilities to report standardized pricing and reimbursement data for common inpatient, surgical, and imaging services, and to provide patients with written price information upon request. It also requires the Department of Health and Human Services and the North Carolina Medical Care Commission to adopt rules to implement reporting, quality-measure, and publication requirements.
The bill also creates new notice and billing protections for insured patients. It requires written disclosures when patients receive care from out-of-network facilities or providers, strengthens fair-billing rules, and gives patients a right to a good-faith estimate for shoppable services, with final bills generally capped at 5% above the estimate when requested. In addition, it limits facility fees for certain outpatient services, requires annual reporting of facility-fee revenue and volume, and authorizes enforcement through unfair-and-deceptive-trade-practice remedies and administrative penalties. The bill further revises utilization review and prior authorization rules, including faster decision timelines, clearer appeal disclosures, website posting of prior authorization requirements, longer validity for some approvals, and a prohibition on using artificial intelligence as the sole basis for denial.
Several provisions would also change state law beyond consumer billing. The bill eliminates certificate-of-need review for inpatient rehabilitation services, rehabilitation facilities, and rehabilitation beds by revising statutory definitions in the CON chapter. It also directs the State Auditor to periodically review prices charged by certain state-funded health service facilities, including prices for uninsured and out-of-network patients, and report on transparency. Separate provisions modify grievance and appeal procedures to allow some employee details to be omitted from review materials, which the bill frames as an employee-safety measure.
The general sentiment reflected in the bill’s text and vote history is strongly supportive of healthcare cost transparency and consumer protection. The Senate adopted an amendment unanimously and passed second reading 44-2, indicating broad bipartisan support with limited opposition at that stage. The bill’s findings and structure present it as a response to high healthcare costs, surprise billing, and lack of price visibility, and the overall tone is pro-consumer and pro-transparency.
The main points of contention are likely to involve the scope and burden of the new reporting, disclosure, and billing restrictions on hospitals, ambulatory surgical facilities, insurers, and providers. Potential concerns include administrative compliance costs, the feasibility of producing accurate good-faith estimates and facility-fee reports, the impact of facility-fee limits on hospital revenue, and the operational effects of tighter prior-authorization and appeal rules. The bill also touches on certificate-of-need policy and AI-based utilization review, which may draw additional debate from providers, insurers, and health-system stakeholders.
The bill would substantially amend Chapter 131E and related insurance statutes by expanding healthcare price-transparency reporting, creating new patient disclosure and billing rights, limiting facility fees, and establishing new enforcement mechanisms under unfair-and-deceptive-trade-practice law. It also revises utilization review and prior authorization requirements in Chapter 58, affects the State Health Plan’s review practices, and removes certificate-of-need review for certain rehabilitation-related facilities and beds. Hospitals, ambulatory surgical facilities, insurers, health systems, and healthcare providers would all be directly affected, along with DHHS, the Medical Care Commission, and the State Auditor.
The available voting record suggests the bill was received favorably in the Senate, with a unanimous vote on an amendment and a 44-2 vote on second reading. The bill’s stated purpose and structure reflect a strong policy preference for lowering costs, increasing transparency, and protecting patients from surprise charges and opaque billing practices. No committee transcript was provided, but the vote margins indicate broad support with only a small amount of opposition.
Likely areas of disagreement include whether the bill’s reporting and disclosure mandates are administratively workable, whether the good-faith estimate and facility-fee restrictions could create compliance or revenue challenges for providers, and whether the prior-authorization changes unduly constrain insurers. Providers and health systems may object to the breadth of price reporting, public disclosure, and enforcement provisions, while insurers may focus on the operational impact of faster utilization review timelines, longer authorization validity, and limits on denial practices. The certificate-of-need repeal for rehabilitation services may also be controversial among stakeholders who support or oppose CON regulation.